Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3117) 3117
antimanic agents - therapeutic use (2788) 2788
science & technology (2585) 2585
life sciences & biomedicine (2571) 2571
bipolar disorder - drug therapy (2229) 2229
psychiatry (2021) 2021
male (1707) 1707
female (1680) 1680
bipolar disorder (1401) 1401
adult (1311) 1311
neurosciences & neurology (1049) 1049
middle aged (1038) 1038
biological and medical sciences (1022) 1022
medical sciences (1011) 1011
antimanic agents - adverse effects (896) 896
psychology. psychoanalysis. psychiatry (823) 823
treatment outcome (804) 804
neurosciences (799) 799
bipolar disorder - psychology (789) 789
lithium (785) 785
antipsychotic agents - therapeutic use (768) 768
clinical neurology (743) 743
pharmacology & pharmacy (730) 730
pharmacology. drug treatments (676) 676
bipolar disorder - diagnosis (662) 662
valproic acid - therapeutic use (650) 650
drug therapy, combination (628) 628
neuropharmacology (566) 566
psychopathology. psychiatry (564) 564
antidepressive agents - therapeutic use (563) 563
psychopharmacology (559) 559
mood disorders (508) 508
adolescent (491) 491
adult and adolescent clinical studies (479) 479
aged (457) 457
anticonvulsants - therapeutic use (436) 436
lithium carbonate - therapeutic use (436) 436
antimanic agents - pharmacology (412) 412
lithium compounds - therapeutic use (403) 403
mania (399) 399
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (399) 399
bipolar disorders (397) 397
psychiatric status rating scales (387) 387
lithium - therapeutic use (374) 374
drug therapy (355) 355
animals (353) 353
antimanic agents - administration & dosage (352) 352
antipsychotic agents - adverse effects (287) 287
antidepressants (282) 282
psychology (282) 282
social sciences (277) 277
bipolar disorder - therapy (243) 243
child (238) 238
valproic acid - adverse effects (236) 236
depression (231) 231
young adult (231) 231
carbamazepine - therapeutic use (230) 230
risk factors (225) 225
care and treatment (223) 223
bipolar disorder - epidemiology (222) 222
double-blind method (216) 216
lithium carbonate - adverse effects (213) 213
retrospective studies (213) 213
follow-up studies (209) 209
dose-response relationship, drug (207) 207
time factors (206) 206
triazines - therapeutic use (205) 205
randomized controlled trials as topic (203) 203
comorbidity (202) 202
valproic acid (194) 194
bipolar disorder - complications (193) 193
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer (192) 192
anticonvulsants - adverse effects (188) 188
analysis (185) 185
bipolar disorder - physiopathology (180) 180
abridged index medicus (169) 169
antidepressive agents - adverse effects (164) 164
lamotrigine (163) 163
research (163) 163
rats (159) 159
acute disease (158) 158
severity of illness index (156) 156
bipolar disorder - genetics (154) 154
clinical trials (154) 154
mental disorders (151) 151
valproate (148) 148
carbamazepine (146) 146
psychology, clinical (145) 145
psychotropic drugs (140) 140
diagnosis, differential (137) 137
health aspects (137) 137
recurrence (137) 137
combined modality therapy (134) 134
neurology (134) 134
general & internal medicine (133) 133
affective disorders (132) 132
lithium compounds - adverse effects (131) 131
medicine, general & internal (131) 131
secondary prevention (131) 131
prospective studies (129) 129
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3145) 3145
French (90) 90
German (80) 80
Spanish (24) 24
Dutch (21) 21
Japanese (15) 15
Portuguese (10) 10
Russian (9) 9
Norwegian (8) 8
Hungarian (7) 7
Hebrew (6) 6
Polish (5) 5
Danish (4) 4
Italian (3) 3
Turkish (3) 3
Greek (2) 2
Swedish (2) 2
Finnish (1) 1
Lithuanian (1) 1
Ukrainian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target
by Pettinati, Helen M and O’Brien, Charles P and Dundon, William D
The American journal of psychiatry, ISSN 0002-953X, 1/2013, Volume 170, Issue 1, pp. 23 - 30
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Desintoxication. Drug withdrawal | Medical sciences | Neuropharmacology | Treatments | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Naltrexone - therapeutic use | Substance-Related Disorders - rehabilitation | Mood Disorders - psychology | Antipsychotic Agents - adverse effects | Humans | Sertraline - adverse effects | Alcoholism - diagnosis | Bipolar Disorder - diagnosis | Depressive Disorder, Major - epidemiology | Psychotropic Drugs - therapeutic use | Mood Disorders - epidemiology | Psychotropic Drugs - adverse effects | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Mood Disorders - rehabilitation | Sertraline - therapeutic use | Drug Therapy, Combination | Alcoholism - psychology | Antimanic Agents - adverse effects | Substance-Related Disorders - diagnosis | Bipolar Disorder - rehabilitation | Antimanic Agents - therapeutic use | Double-Blind Method | Comorbidity | Narcotic Antagonists - adverse effects | Depressive Disorder, Major - rehabilitation | Combined Modality Therapy | Controlled Clinical Trials as Topic | Alcoholism - epidemiology | Alcoholism - rehabilitation | Bipolar Disorder - psychology | Antidepressive Agents - therapeutic use | Depressive Disorder, Major - psychology | Narcotic Antagonists - therapeutic use | Mood Disorders - diagnosis | Substance-Related Disorders - psychology | Cognitive Therapy | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Naltrexone - adverse effects | Bipolar Disorder - epidemiology | Diagnosis, Dual (Psychiatry) | Psychological aspects | Drug abuse | Care and treatment | Physiological aspects | Mood (Psychology) | Psychotherapy | Health aspects | Methods | Bipolar disorder | Mental depression | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder
by Post, Robert M and Altshuler, Lori L and Frye, Mark A and Suppes, Trisha and Keck, Paul E and McElroy, Susan L and Leverich, Gabriele S and Luckenbaugh, David A and Rowe, Michael and Pizzarello, Scott and Kupka, Ralph W and Grunze, Heinz and Nolen, Willem A
The journal of clinical psychiatry, ISSN 0160-6689, 09/2010, Volume 71, Issue 9, pp. 1176 - 1186
I DISORDER | TREATMENT ENHANCEMENT PROGRAM | MAINTENANCE TREATMENT | DEPRESSED-PATIENTS | CLINICAL-TRIALS | DOUBLE-BLIND | 18-MONTH TRIAL | ANTIDEPRESSANT DISCONTINUATION | ILLNESS | UMCG Approved | STEP-BD | Psychology, Clinical | Social Sciences | Life Sciences & Biomedicine | Psychiatry | Psychology | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Medical sciences | Bipolar disorders | Triiodothyronine - adverse effects | Prospective Studies | Follow-Up Studies | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Secondary Prevention | Bipolar Disorder - diagnosis | Triiodothyronine - therapeutic use | Thyroxine - adverse effects | Psychiatric Status Rating Scales | Anticonvulsants - adverse effects | Clonazepam - adverse effects | Antipsychotic Agents - therapeutic use | Adult | Anti-Anxiety Agents - adverse effects | Female | Valproic Acid - therapeutic use | Thyroxine - therapeutic use | Anti-Anxiety Agents - therapeutic use | Drug Therapy, Combination | Valproic Acid - adverse effects | Antimanic Agents - adverse effects | Clonazepam - therapeutic use | Antimanic Agents - therapeutic use | Anticonvulsants - therapeutic use | Treatment Outcome | Bipolar Disorder - drug therapy | Ambulatory Care | Bipolar Disorder - psychology | Antidepressive Agents - therapeutic use | Lithium Carbonate - therapeutic use | Antidepressive Agents - adverse effects | Lithium Carbonate - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults with Bipolar Depression (EMBOLDEN II)
by McElroy, Susan L and Weisler, Richard H and Chang, William and Olausson, Bengt and Paulsson, Björn and Brecher, Martin and Agambaram, Vasavan and Merideth, Charles and Nordenhem, Arvid and Young, Allan H and EMBOLDEN II Trial D1447C00134 Inve and EMBOLDEN II (Trial D1447C00134) Investigators
The journal of clinical psychiatry, ISSN 0160-6689, 02/2010, Volume 71, Issue 2, pp. 163 - 174
Psychology, Clinical | Social Sciences | Life Sciences & Biomedicine | Psychiatry | Psychology | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Bipolar disorders | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psycholeptics: tranquillizer, neuroleptic | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Severity of Illness Index | Antidepressive Agents, Second-Generation - adverse effects | Antimanic Agents - therapeutic use | Double-Blind Method | Humans | Middle Aged | Quetiapine Fumarate | Male | Treatment Outcome | Paroxetine - therapeutic use | Antidepressive Agents, Second-Generation - therapeutic use | Bipolar Disorder - drug therapy | Paroxetine - adverse effects | Antidepressive Agents - therapeutic use | Psychiatric Status Rating Scales | Dibenzothiazepines - therapeutic use | Dibenzothiazepines - adverse effects | Adolescent | Placebos | Adult | Female | Aged | Antidepressive Agents - adverse effects | Antimanic Agents - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder
by Woodward, Tatia Chay and Tafesse, Eskinder and Quon, Peter and Lazarus, Arthur
PharmacoEconomics, ISSN 1170-7690, 9/2010, Volume 28, Issue 9, pp. 751 - 764
Quality of Life Research | Health Economics | Health Administration | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | bipolar-i-disorders, treatment | lithium, therapeutic use | aripiprazole, therapeutic use | olanzapine, therapeutic use | antipsychotics, therapeutic use | cost-utility | valproate-semisodium, therapeutic use | lamotrigine, therapeutic use | quetiapine, therapeutic use | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Pharmacology & Pharmacy | Business & Economics | Health Policy & Services | Science & Technology | Public health. Hygiene | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Bipolar disorders | Public health. Hygiene-occupational medicine | Psycholeptics: tranquillizer, neuroleptic | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Piperazines - administration & dosage | Quinolones - economics | Dibenzothiazepines - economics | Lithium Compounds - economics | Markov Chains | Tablets | Triazines - therapeutic use | United States | Humans | Piperazines - economics | Risk | Absenteeism | Models, Economic | Aripiprazole | Dibenzothiazepines - therapeutic use | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Valproic Acid - therapeutic use | Benzodiazepines - economics | Antipsychotic Agents - economics | Hospital Charges | Quality-Adjusted Life Years | Antimanic Agents - therapeutic use | Quetiapine Fumarate | Antimanic Agents - economics | Bipolar Disorder - economics | Piperazines - therapeutic use | Delayed-Action Preparations - economics | Antimanic Agents - administration & dosage | Bipolar Disorder - mortality | Drug Therapy, Combination - economics | Bipolar Disorder - drug therapy | Dibenzothiazepines - administration & dosage | Antipsychotic Agents - administration & dosage | Health Care Costs | Quinolones - administration & dosage | Valproic Acid - administration & dosage | Lithium Compounds - therapeutic use | Triazines - administration & dosage | Cost-Benefit Analysis | Benzodiazepines - administration & dosage | Fees, Pharmaceutical | Triazines - economics | Benzodiazepines - therapeutic use | Lithium Compounds - administration & dosage | Valproic Acid - economics | antipsychotics; therapeutic use; aripiprazole; therapeutic use; bipolar-i-disorders; treatment; cost-utility; lamotrigine; therapeutic use; lithium; therapeutic use; olanzapine; therapeutic use; quetiapine; therapeutic use; valproate-semisodium; therapeutic use. | Economic aspects | Bipolar disorder | Dosage and administration | Research | Drug therapy | Quetiapine | Medical care, Cost of | Health care | Studies | Costs | Economic theory | Mathematical analysis | Medical treatment | Pharmaceuticals
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review
by Buoli, Massimiliano and Serati, Marta and Altamura, A. Carlo
Journal of affective disorders, ISSN 0165-0327, 2013, Volume 152, Issue 1, pp. 12 - 18
Psychiatry | Mood stabilizers | Antipsychotics | Combined treatment | Bipolar Disorder | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Bipolar disorders | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psycholeptics: tranquillizer, neuroleptic | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Piperazines - administration & dosage | Humans | Thiazoles - administration & dosage | Long-Term Care | Thiazoles - therapeutic use | Aripiprazole | Dibenzothiazepines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Drug Therapy, Combination | Antimanic Agents - therapeutic use | Quetiapine Fumarate | Risperidone - administration & dosage | Treatment Outcome | Piperazines - therapeutic use | Antimanic Agents - administration & dosage | Bipolar Disorder - drug therapy | Dibenzothiazepines - administration & dosage | Antidepressive Agents - therapeutic use | Antipsychotic Agents - administration & dosage | Quinolones - administration & dosage | Antidepressive Agents - administration & dosage | Benzodiazepines - administration & dosage | Benzodiazepines - therapeutic use | Bipolar disorder | Antipsychotic drugs | Drug therapy | Antidepressants | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials
by Solmi, Marco and Veronese, Nicola and Zaninotto, Leonardo and van der Loos, Marc L. M and Gao, Keming and Schaffer, Ayal and Reis, Catherine and Normann, Claus and Anghelescu, Ion-George and Correll, Christoph U
CNS spectrums, ISSN 1092-8529, 10/2016, Volume 21, Issue 5, pp. 403 - 418
Original Research | bipolar disorder | major depressive disorder | trials | unipolar depression | lamotrigine | Bipolar depression | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Antimanic Agents - therapeutic use | Triazines - therapeutic use | Vitamin B Complex - therapeutic use | Humans | Anticonvulsants - therapeutic use | Bipolar Disorder - drug therapy | Antidepressive Agents - therapeutic use | Depression - drug therapy | Lithium - therapeutic use | Inositol - therapeutic use | Antipsychotic Agents - therapeutic use | Citalopram - therapeutic use | Fluoxetine - therapeutic use | Benzodiazepines - therapeutic use | Drug Combinations | Depressive Disorder, Major - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efficacy of Adjunctive Aripiprazole to Either Valproate or Lithium in Bipolar Mania Patients Partially Nonresponsive to Valproate Lithium Monotherapy: A Placebo-Controlled Study
by Vieta, Eduard and T'joen, Caroline and McQuade, Robert D and Carson, William H and Marcus, Ronald N and Sanchez, Raymond and Owen, Randall and Nameche, Laurence
The American journal of psychiatry, ISSN 0002-953X, 10/2008, Volume 165, Issue 10, pp. 1316 - 1325
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Antimanic Agents - therapeutic use | Double-Blind Method | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Anticonvulsants - therapeutic use | Male | Piperazines - therapeutic use | Lithium Compounds - adverse effects | Aripiprazole | Piperazines - adverse effects | Dose-Response Relationship, Drug | Psychiatric Status Rating Scales | Anticonvulsants - adverse effects | Quinolones - adverse effects | Lithium Compounds - therapeutic use | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Adult | Female | Valproic Acid - therapeutic use | Drug Therapy, Combination | Valproic Acid - adverse effects | Antimanic Agents - adverse effects | Bipolar disorder | Dosage and administration | Drug therapy | Psychotropic drugs | Studies | Illnesses | Manic depression | Clinical trials | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Lithium Use in Pregnancy and the Risk of Cardiac Malformations
by Patorno, Elisabetta and Huybrechts, Krista F and Bateman, Brian T and Cohen, Jacqueline M and Cohen, Lee S and Desai, Rishi J and Mogun, Helen and Hernandez-Diaz, Sonia
The New England journal of medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 23, pp. 2245 - 2254
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antimanic Agents - therapeutic use | Heart Defects, Congenital - chemically induced | Prevalence | Triazines - therapeutic use | Humans | Anticonvulsants - therapeutic use | Infant | Lithium Compounds - adverse effects | Bipolar Disorder - drug therapy | Pregnancy Trimester, First | Pregnancy Complications - drug therapy | Antidepressive Agents - therapeutic use | Pregnancy | Young Adult | Anticonvulsants - adverse effects | Lithium Compounds - therapeutic use | Heart Defects, Congenital - epidemiology | Adult | Female | Triazines - adverse effects | Antidepressive Agents - adverse effects | Antimanic Agents - adverse effects | Infant, Newborn | Cohort Studies | Heart failure | Lithium | Usage | Health aspects | Risk factors | Heart | Congenital diseases | Mental disorders | Bipolar disorder | Birth defects | Infants | Mood | Maternal & child health | Ventricle | Health risk assessment | Drug therapy | Heart diseases | Lamotrigine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights